Last updated: August 17, 2020
Sponsor: Rheinhessen-Fachklinik Alzey
Overall Status: Active - Recruiting
Phase
N/A
Condition
Memory Problems
Memory Loss
Treatment
N/AClinical Study ID
NCT04516863
D-AMI 1.1
Ages 18-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
MDD
HDRS > 17
Age 18-80
Ability to give informed consent
Exclusion
Exclusion Criteria:
Drugs or drug abuse or addictions
Use of benzodiazepine equivalent to lorazepam> 1.5 mg per day
Cognitive impairments
History of traumatic brain injury
Relevant organic disease, e.g. Multiple sclerosis, Parkinson's disease
Bipolar illness, dementia or schizophrenic disorder
German is not the mother tongue
Inability to give informed consent
Study Design
Total Participants: 60
Study Start date:
August 15, 2020
Estimated Completion Date:
May 01, 2021
Study Description
Connect with a study center
Rheinhessen-Fachklinik Alzey
Alzey, Rheinland-Pfalz 55232
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.